Fatima K Alduraibi (Fatima Alduraibi)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Rheumatoid Arthritis

Ankylosing Spondylitis

Diabetic Nephropathy

Disease Activity

Top Venues

Current rheumatology reports

International journal of molecular sciences

The Journal of rheumatology

Arthritis research & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Fatima K Alduraibi, George C Tsokos
Lupus Nephritis Biomarkers: A Critical Review. International journal of molecular sciences 25 (2) (2024)
Fatima K Alduraibi, George C Tsokos
Lupus Nephritis Biomarkers: A Critical Review. International journal of molecular sciences 25 (2) (2024)
Fatima K Alduraibi, George C Tsokos
Lupus Nephritis Biomarkers: A Critical Review. International journal of molecular sciences 25 (2) (2024)
Fatima K Alduraibi, Jasvinder A Singh
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits. Current rheumatology reports 25 (12) (2023)
Fatima K Alduraibi, Jasvinder A Singh
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits. Current rheumatology reports (2023)
Fatima K Alduraibi, Jasvinder A Singh
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits. Current rheumatology reports 25 (12) (2023)
Fatima K Alduraibi, Jasvinder A Singh
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits. Current rheumatology reports 25 (12) (2023)
Fatima K Alduraibi, Mohammad Saleem, Karina Ricart, Rakesh P Patel, Alexander J Szalai, Jasvinder A Singh
Clustering Patients With Gout Based on Comorbidities and Biomarkers: A Cross-Sectional Study. The Journal of rheumatology (2022)
Fatima K Alduraibi, Huma Fatima, Jennie A Hamilton, W Winn Chatham, Hui-Chen Hsu, John D Mountz
Lupus nephritis correlates with B cell interferon-β, anti-Smith, and anti-DNA: a retrospective study. Arthritis research & therapy 24 (1) (2022)